Researchers have found bacteria often associated with hospital infections in meat samples from markets in Peru. The Barcelona Institute for Global Health (ISGlobal) led the study, published in the ...
A research team has discovered a fundamental mechanism that helps the dreaded hospital pathogen Acinetobacter baumannii to survive. This mechanism explains why the pathogen is difficult to eradicate ...
Hospital-acquired infections are often hard to treat because the corresponding pathogens become increasingly resistant against antibiotics. The bacterium Acinetobacter baumannii is particularly feared ...
Acinetobacter bacteria are not airborne, but can be spread through direct contact with surfaces, objects, or the skin of people that are contaminated with A. baumannii. Bloodstream infections often ...
Credit: Getty Images. A PDUFA target date of May 29, 2023 has been set for the application. The Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee unanimously voted 12-0 in ...
A research team led by Beate Averhoff and Volker Müller of Goethe University Frankfurt has discovered a fundamental mechanism that helps the dreaded hospital pathogen Acinetobacter baumannii to ...
XACDURO is a new FDA-approved treatment used to fight against HABP/VABP infections caused by isolates of Acinetobacter baumannii-calcoaceticus complex, which can include those resistant to carbapenems ...
Class A enzymes include β-lactamases that are active against penicillins and cephalosporins as well as extended-spectrum β-lactamases that are also active against penicillins and cephalosporins and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results